THE PROBLEM OF ANTIBIOTIC RESISTANCE OF HELICOBACTER PYLORI ON THE MODERN STAGE AND ITS CLINICAL SIGNIFICANCE FOR PRACTICAL MEDICINE
https://doi.org/10.21886/2219-8075-2015-1-26-34
Abstract
Th e article off ers an analysis of the literature of recent years dedicated to the development and prevalence of Helicobacter pylori resistance to various antibiotics, which are used for the eradication of this microorganism. Th e reasons of the growth of Helicobacter pylori antibiotic resistance at the present stage have been considered. Th e author describes specifi c issues surrounding diff erent therapeutic options, the ways to overcome this pathogen’s resistance, and the necessary steps in choosing the correct eradication regimens, according to the level of Helicobacter pylori antibiotic resistance. Particular attention is paid to the prevalence of antibiotic resistance of Helicobacter pylori in childhood.
About the Author
A. V. Nalyotov
Donetsk National Medical University named aft er M. Gorky, Department №2 for Pediatrics
Russian Federation
Russian Federation
References
1. Циммерман Я.С. Нерешенные и спорные проблемы современной гастроэнтерологии. – М.: МЕДпресс-информ, 2013. – 224 с.
2. Клиническое значение инфекции Helicobacter pylori / И.В. Маев, Д.Н. Самсонов, А.А. Андреев [и др.] // Клиническая медицина. – 2013. – № 8. – С. 4-13.
3. Современные аспекты диагностики и лечения инфекции Helicobacter pylori / И.В. Маев, Д.Н. Самсонов, А.А. Андреев [и др.] // Медицинский Совет. – 2012. − № 8. – C. 10-19.
4. Файзуллина Р.А. Факторы патогенности и вирулентности Helicobacter pylori и их роль в развитии хеликобактер-ассоциированной гастродуоденальной патологии / Р.А. Файзуллина, Е.В. Абдуллина // Практическая медицина. – 2011. - № 1 (49). – С. 74-78.
5. Castro-Fernаndez M. Infection with Helicobacter pylori. Prevalence, research and impact of antibiotic resistance / M. Castro-Fernandez, J. Vargas-Romero // Rev. Esp. Enferm. Dig. – 2009. – Vol. 101, № 11. – Р. 743-756.
6. Worldwide H. pylori antibiotic resistance: a systematic review / V. De Francesco, F. Giorgio, C. Hassan [et al.] // J. Gastrointestin. Liver Dis. – 2010. – Vol. 19, № 4. – Р. 409-414.
7. Урсова Н.И. Хеликобактерная инфекция у детей: проблема, анализ обобщенных данных / Н.И. Урсова // Лечащий врач. – 2009. – №6. – С. 43-46.
8. Helicobacter Pylori in developing countries. World Gastroenterology Organisation Global Guideline // R.H. Hunt, S.D. Xiao, F. Megraud [et al.] // J. Gastrointestin. Liver Dis. – 2011. – Vol. 20, № 3. – P. 299-304.
9. Щербаков П.Л. Особенности хеликобактериоза у детей России / П.Л. Щербаков // Экспериментальная и клиническая гастроентерология. – 2008. – № 8. – С.46-52.
10. Рафальский В.В. Рекомендации Маастрихт IV: выбор схемы эрадикации в эру роста антибиотикорезистентности
11. H.pylori / В.В. Рафальский // Вестник практического врача. – 2012. – Спецвып. 1. – С. 27-33.
12. Исаков В.А. Диагностика и лечение инфекции, вызванной Helicobacter pylori: IV Маастрихтское соглашение / Новые рекомендации по диагностике и лечению инфекции H.Pylori – Маастрихт IV (Флоренция) / В.А. Исаков // Best Clinical Practice. Русское издание. – 2012. – Вып. 2. – С. 4-23.
13. Management of Helicobacter pylori infection – the Maastricht IV / Florence Consensus Report / Р. Malfertheiner, С.А. O’Morain, F. Megraud [еt al.] // Gut. – 2012. – Vol. 61, № 5. – Р. 646-664.
14. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption / F. Megraud, S. Coenen, A. Versporten [et al.] // Gut. – 2013. – Vol. 62, № 1. – Р. 34-42.
15. Megraud F. H.pylori antibiotic resistance: prevalence, importance, and advances in testing / F.Н. Megraud // Gut. – 2004. – Vol. 53, № 5. – P. 1374-1384.
16. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption / F. Megraud, S. Coenen, A. Versporten [et al.] // Gut. – 2013. – Vol. 62, № 1. – Р. 34-42.
17. Исаева Г.Ш. Резистентность H. pylori к антибактериальным препаратам и методы ее определения / Г.Ш. Исаева // Клиническая микробиология и антимикробная химиотерапия – 2010. - № 1. – С. 57-66.
18. Antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe: results of a prospective multicenter study from 1999-2002 / S. Koletzko, D. Antos, F. Richy [et al.] // J. Ped. Gastroenterol. Nutr. – 2004. – Vol. 39, suppl. 1. – P. S252.
19. Prospective multicenter study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe / S. Koletzko, F. Richy, P. Bontems [et al.] // Gut. – 2006. – Vol. 55, № 12. – P. 1711-1716.
20. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori / V. De Francesco, M. Margiotta, A. Zullo [et al.] // Ann. Inter. Med. – 2006. – Vol. 144. – 94-100.
21. Contribution of effl ux pumps to clarithromycin resistance in Helicobacter pylori / K. Hirata, H. Suzuki, T. Nishizawa [et al.] // J. Gastroenterol. Hepatol. – 2010. – Vol. 25, suppl. 1. – S.75-79.
22. Paulsen I.T. Multidrug effl ux pumps and resistance: regulation and evolution / I.T. Paulsen // Curr. Opin. Microbiol. – 2003. – Vol. 6. – P. 446-451.
23. Щербаков А.П. Ведение хеликобактерной инфекции у детей (научно обоснованные рекомендации ESPGHAN и NASPGHAN 2010) / А.П. Щербаков, П.Л. Щербаков // Лечащий врач. – 2011. – № 6. – С. 46-58.
24. Фадеенко Г.Д. Лечение инфекции Н. pylori: настоящее и будущее / Г.Д. Фадеенко // Medicus Amicus. – 2004. – № 1. – C. 6-9.
25. Кудрявцева Л.В. Состояние антибиотикорезистентности Helicobacter pylori в России / Л.В. Кудрявцева // Экспериментальная и клиническая гастроэнтерология. – 2003. – № 3. – С. 4-5.
26. Moore J.M. Mutational analysis of metronidazole resistance in Helicobacter pylori / J.M. Moore, N.R. Salama // Antimicrob. Agents Chemother. – 2005. – Vol. 49. – P. 1236-1237.
27. Pajares Garcia J.M. Helicobacter pylori infection: antibiotic resistance / J.M. Pajares Garcia, R. Pajares-Villarroya, J.P. Gisbert // Rev. Esp. Enferm. Dig. – 2007. – Vol. 99, № 2. – Р. 63-70.
28. Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication / H. Fakheri, S. Merat, V. Hosseini [et al.] // Aliment. Pharmacol. Th er. – 2004. – Vol. 19, № 1. – P. 89-93.
29. Fischbach L. Meta-analysis: the eff ect of antibiotic resistance status on the effi cacy of triple and quadruple fi rst-line therapies for Helicobacter pylori / L. Fischbach, E.L. Evans // Aliment. Pharmacol. Th er. – 2007. – Vol. 26. – P. 343-357.
30. Ma H.J. Quadruple therapy for eradication of Helicobacter pylori / H.J. Ma, J.L. Wang // World J. Gastroenterol. – 2013. – Vol. 19, № 6. – Р. 931-935.
31. Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis / A. Zullo, E. Ierardi, C. Hassan [et al.] // Saudi journal of gastroenterology: offi cial journal of the Saudi Gastroenterology Association. – 2012. – Vol. 18, №1. – Р. 11-7.
32. Tetracycline- and Furazolidone-containing Quadruple Regimen as Rescue Treatment for Helicobacter pyloriInfection: A Single Center Retrospective Study / Y. Zhang, W. Gao, H. Cheng [et al.] // Helicobacter. – 2014. – May 21.
33. Th e problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America / M.C. Camargo, A. Garcia, A. Riquelme [et al.] // Am. J. Gastroenterol. – 2014. – Vol.109, № 4. – Р. 485-495.
34. Risk factors for Helicobacter py lori resistance in the United States: the surveillance of H. pylori antimi crobial resistance partnership (SHARP) study, 1993-1999 / J.M. Meyer, N.P. Silliman, W. Wang [et al.] // Ann. Intern. Med. – 2002. –
35. Vol. 136, № 1. – P. 13-24.
36. Graham D.Y. Helicobacter pylori treatment in the era of increasing antibiotic resistance / D.Y. Graham, L. Fischbach. // Gut. – 2010. – Vol. 5, № 8. – Р. 1143-1153.
37. Qureshi N.N. Contribution of specifi c amino acid changes in penicillin binding protein 1 to amoxicillin resistance in clinical Helicobacter pylori isolates / N.N. Qureshi, D. Morikis, N.L. Schiller // Antimicrob. Agents Chemother. – 2011. – Vol. 55, №1. – Р. 101-109.
38. Nonaka L. 16S rRNA mutations that confer tetracycline resistance in Helicobacter pylori decrease drug binding in Escherichia coli ribosomes / L. Nonaka, S.R. Connell, D.E. Taylor // J. Bacteriol. – 2005. – Vol. 187, №11. – Р. 3708-3712.
39. Sitafl oxacin activity against Helicobacter pylori isolates, including those with gyrA mutations / K. Murakami, T. Okimoto, M. Kodama [et al.] // Antimicrob. Agents Chemother. 2009. – Vol. 53, № 7. – Р. 3097-3099.
40. Prevalence and mechanisms of resistance to fl uoroquinolones in Helicobacter pylori strains from patients living in Belgium / P. Bogaerts, C. Berhin, H. Nizet [et.al.] // Helicobacter. – 2006. – Vol. 11. – P. 441-445.
41. Practical treatment of Helicobacter pylori: a balanced view in changing times / S.M. Smith, R.B. Haider, H. O’Connor [et. al] // J. Gastroenterol. Hepatol. – 2014. – Vol. 26, № 8. – Р. 819-825.
42. Eradication of Helicobacter pylori infection / T.S. Wu, H.M. Hu, F.C. Kuo [et. al] // Kaohsiung J. Med. Sci. – 2014. – Vol. 30, № 4. – Р. 167-172.
Review
For citations:
Nalyotov A.V. THE PROBLEM OF ANTIBIOTIC RESISTANCE OF HELICOBACTER PYLORI ON THE MODERN STAGE AND ITS CLINICAL SIGNIFICANCE FOR PRACTICAL MEDICINE. Medical Herald of the South of Russia. 2015;(1):26-34. (In Russ.) https://doi.org/10.21886/2219-8075-2015-1-26-34
Views:
472
Email this article 